CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

BMRN Stock Up as Q2 Earnings Beat on Sales Growth, 2026 Outlook Raised

EarningsPositive
AI Analysis

Summary

Biomarin Pharmaceutical reported Q2 earnings that beat expectations with sales growth and raised its 2026 outlook, driving stock gains.

Financial Highlights

Guidance

2026 outlook raised

Importance:5/10
Sentiment:
0.70
earningsQ2sales growthguidance raise
Related Companies

Read the original article

Published by yahoo_finance on August 7, 2026 3:50 PM

Read Original